Page last updated: 2024-09-05

ly 300164 and cilengitide

ly 300164 has been researched along with cilengitide in 1 studies

Compound Research Comparison

Studies
(ly 300164)
Trials
(ly 300164)
Recent Studies (post-2010)
(ly 300164)
Studies
(cilengitide)
Trials
(cilengitide)
Recent Studies (post-2010) (cilengitide)
7371219429133

Protein Interaction Comparison

ProteinTaxonomyly 300164 (IC50)cilengitide (IC50)
Integrin beta-3Homo sapiens (human)0.3087
Integrin beta-1Homo sapiens (human)1.0131
Integrin alpha-V Homo sapiens (human)0.514
Integrin alpha-IIbHomo sapiens (human)2.399
Integrin alpha-5Homo sapiens (human)0.9006
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.0005
Integrin beta-5Homo sapiens (human)0.4791
Integrin beta-6Homo sapiens (human)4.042
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.0005
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.0005

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Desideri, S; Fisher, J; Grossman, SA; Nabors, LB; Piantadosi, S; Rosenfeld, M; Ye, X1

Other Studies

1 other study(ies) available for ly 300164 and cilengitide

ArticleYear
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Benzodiazepines; Biomedical Research; Brain Neoplasms; Carboxymethylcellulose Sodium; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Drug Therapy, Combination; Female; Glioblastoma; Humans; Interferon Inducers; Male; Middle Aged; Poly I-C; Polylysine; Receptors, AMPA; Snake Venoms; Survival Rate; Temozolomide; Treatment Outcome; United States; Young Adult

2010